Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,791 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,315 · Balance 8,791 F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.78 · Expires 2036-06-08 | Direct | 5,853 |
Reported balance
After 2026-06-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-09 · Grant · Acquired 5,853 · Balance 5,853 F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date February 05, 2024 · Filed February 07, 2024
Section 16 reporting ended · disclosed 2024-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,005 |
Ending reported balance
After 2024-02-05 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2024-02-05 · Tax withholding · Disposed 2,208 · Balance 25,524 Row 2 · 2024-02-05 · Tax withholding · Disposed 1,077 · Balance 24,447 Row 3 · 2024-02-05 · Tax withholding · Disposed 213 · Balance 24,234 Row 4 · 2024-02-05 · Sale · Disposed 300 · Balance 23,934 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 5 · 2024-02-05 · Sale · Disposed 1,703 · Balance 22,231 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Row 6 · 2024-02-05 · Sale · Disposed 1,226 · Balance 21,005 F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023. F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
Filing footnotes · ownership attribution and instrument terms
F1: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/08/2023.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $229.12 to $229.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.67 to $231.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.70 to $232.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $172.83 | $17,283.00 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,588 F8 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $172.59 to $173.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 50 | $171.34 | $8,567.00 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,688 F7 · price: The reported securities were sold at a price of $171.34. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 356 | $170.61 | $60,737.16 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,738 F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $170.25 to $171.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 750 | $169.46 | $127,095.00 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,094 F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $169.16 to $170.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 552 | $168.61 | $93,072.72 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,844 F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $168.02 to $169.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 406 | $167.24 | $67,899.44 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,396 F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $167.02 to $167.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 486 | $166.47 | $80,904.42 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,802 F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $165.93 to $166.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 22:12 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 1,500 | $17.00 | $25,500.00 |
DisclosureSEC source: 0001209191-21-070789 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 2,249 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · derivative · entry 14 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,247 Underlying: Common Stock · 2,249 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F13 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionStock Option · Derivative | 251 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · derivative · entry 13 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,259 Underlying: Common Stock · 251 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F12 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 150 | $223.51 | $33,526.50 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 12 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F11 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $223.39 to $223.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 835 | $222.66 | $185,921.10 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 11 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,938 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F10 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $222.33 to $223.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $221.56 | $44,312.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,773 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F9 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $221.25 to $222.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 151 | $220.46 | $33,289.46 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,973 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F8 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $220.19 to $220.96. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $219.57 | $65,871.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,124 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.15 to $220.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $218.43 | $21,843.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,424 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.95 to $218.91. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 164 | $217.14 | $35,610.96 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,524 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.82 to $217.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $215.91 | $43,182.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,688 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.59 to $216.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 251 | $215.02 | $53,970.02 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,888 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $214.49 to $215.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 149 | $213.18 | $31,763.82 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,139 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.90 to $213.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 2,249 | $17.00 | $38,233.00 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:21 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 251 | $4.03 | $1,011.53 |
DisclosureSEC source: 0001209191-21-062462 · doc4.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,249 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · derivative · entry 11 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,496 Underlying: Common Stock · 2,249 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F10 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 251 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · derivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Underlying: Common Stock · 251 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F9 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 500 | $199.87 | $99,935.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F8 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $199.40 to $200.15. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $198.52 | $59,556.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,288 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $198.15 to $199.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $197.15 | $19,715.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,588 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. All of the reported securities in this row were sold at a price of $197.15. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 600 | $194.95 | $116,970.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,688 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $194.38 to $195.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $193.77 | $58,131.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,288 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.37 to $194.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 600 | $192.39 | $115,434.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,588 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $192.06 to $193.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $189.45 | $18,945.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,188 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. All of the reported securities in this row were sold at a price of $189.45. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 251 | $4.03 | $1,011.53 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:30 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 2,249 | $17.00 | $38,233.00 |
DisclosureSEC source: 0000950103-21-015430 · dp159352_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,249 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · derivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,745 Underlying: Common Stock · 2,249 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F8 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. F10 · balance_after: The holdings reported on 6/1/2021 for this option were inadvertently reported as 31,665 and should have been reported as 30,808. The holdings in this form are correct. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 251 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · derivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,761 Underlying: Common Stock · 251 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. F9 · balance_after: The holdings reported on 4/19/2021 for this option were inadvertently reported as 5,066 and should have been reported as 4,724. The holdings in this form are correct. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 300 | $218.14 | $65,442.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.08 to $218.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 1,721 | $217.49 | $374,300.29 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,088 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $216.92 to $217.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 100 | $215.75 | $21,575.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 5 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,809 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The reported securities were sold at a price of $215.75 Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $214.33 | $42,866.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 4 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,909 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F3 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $214.31 to $214.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 179 | $213.13 | $38,150.27 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 3 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,109 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.85 to $213.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 251 | $4.03 | $1,011.53 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 2 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 01:28 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionCommon Stock | 2,249 | $17.00 | $38,233.00 |
DisclosureSEC source: 0000950103-21-013552 · dp157479_4-puckett.xml · nonDerivative · entry 1 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,907 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · derivative · entry 13 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,994 Underlying: Common Stock · 1,907 shares Expires 2029-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F11 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 03/06/2019. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 251 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · derivative · entry 12 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012 Underlying: Common Stock · 251 shares Expires 2028-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F10 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/19/2018. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 342 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · derivative · entry 11 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 342 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F9 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest monthly from 07/21/2017. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $183.69 | $36,738.00 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · nonDerivative · entry 10 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,788 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F8 · price: The price reported in Column 4 were sold at a price of $183.69. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 200 | $181.93 | $36,386.00 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · nonDerivative · entry 9 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,988 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F7 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $181.52 to $182.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 672 | $177.90 | $119,548.80 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · nonDerivative · entry 8 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,188 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F6 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $177.43 to $178.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 602 | $176.95 | $106,523.90 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · nonDerivative · entry 7 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,860 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F5 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $176.40 to $177.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:00 UTC | Shockwave Medical, Inc. SWAV · Entity 90374 | SaleCommon Stock | 251 | $173.34 | $43,508.34 |
DisclosureSEC source: 0000950103-21-011929 · dp155802_4-puckett.xml · nonDerivative · entry 6 PUCKETT DAN · CIK 0001602773 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,462 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019. F4 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $173.03 to $173.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.